Facible BioDiagnostics, Inc. — Form D
Facible BioDiagnostics, Inc. of MERIDIAN, ID, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-06. The offering totals $1.8M, of which $862K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-06
- Form: D
- Accession: 0001888078-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $862K
- Remaining: $980K
- Investors: 3
- Date of first sale: 2022-05-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-444739
Issuer
- Name: Facible BioDiagnostics, Inc.
- CIK: 0001910594
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 366 SW 5TH AVE, MERIDIAN, ID, 83642
- Phone: 8013616686
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Steven Burden | Director | MERIDIAN, ID |
| Matthew Hawkins | Director | Toronto, A6 |
| Eric Hayden | Director | MERIDIAN, ID |
| Casi Wyatt | Director | MERIDIAN, ID |
| Steven Burden | Executive Officer | MERIDIAN, ID |
| Brent Fawson | Executive Officer | MERIDIAN, ID |
| Clementine Gibard Bohachek | Executive Officer | MERIDIAN, ID |
| Micah Kormylo | Executive Officer | MERIDIAN, ID |
Other filings by this issuer (1)
More